ExLibris header image
SFX Logo
Title: Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Source:

Nature Communications [2041-1723] yr:2015


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Dufva, O. "Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target." Nature Communications 9.1 (2018): 1567-1567. Link to Full Text for this item Link to SFX for this item
2. "Arachidonic acid, a clinically adverse mediator in the ovarian cancer microenvironment, impairs JAK‐STAT signaling in macrophages by perturbing lipid raft structures." Molecular oncology. 16.17: 3146-3166. Link to SFX for this item
3. Yang, Q. "Early life developmental exposure to endocrine disrupting chemicals increases the risk of adult onset of uterine fibroids by permanently reprograming the epigenome of myometrial stem cells towards a pro-fibroid landscape." Fertility and sterility 106.3 (2016). Link to SFX for this item
4. Lamas, B. "Leptin modulates dose‐dependently the metabolic and cytolytic activities of NK‐92 cells." Journal of cellular physiology 228.6 (2013): 1202-. Link to Full Text for this item Link to SFX for this item
5. "Aggressive NK-cell leukemia with cutaneous involvement associated with reactive hemophagocytic syndrome." Journal of the American Academy of Dermatology 52.3 (2005). Link to SFX for this item
6. "Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders." Cancers. 14.10: 2483-. Link to SFX for this item
7. "Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas." Nature communications. 11.1: 1806-14. Link to SFX for this item
8. Wang QS, Q. "Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia." Molecular therapy 23.1 (2014): 184-191. Link to Full Text for this item Link to SFX for this item
9. "The association between genetically elevated polyunsaturated fatty acids and risk of cancer." EBioMedicine. 91: 104510-. Link to SFX for this item
10. Moffitt, Andrea B. "Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2." The Journal of experimental medicine 214.5 (2017): 1371-1386. Link to Full Text for this item Link to SFX for this item
11. "Lymphoproliferative Disorders." Obesity, Fitness & Wellness Week (2016): 1513-. Link to SFX for this item
12. O'Hear, C. "ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR THERAPY FOR ACUTE MYELOID LEUKEMIA." Pediatric blood & cancer 61 (2014). Link to Full Text for this item Link to SFX for this item
13. Turtle, Cameron J. "CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients." Journal of Clinical Investigation 126.6 (2016): 2123-2138. Link to Full Text for this item Link to SFX for this item
14. Hanren Dai, H. "Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia." Oncoimmunology 4.11 (2015): 1027469-00. Link to Full Text for this item Link to SFX for this item
15. Casati, A. "Clinical-scale selection and viral transduction of human naïve and central memory CD8(+) T cells for adoptive cell therapy of cancer patients." Cancer immunology and immunotherapy 62.10 (2013): 1563-73. Link to Full Text for this item Link to SFX for this item
16. Yu, J. "CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance In Vitro and In Vivo anti-tumor activity against human multiple myeloma." Leukemia 28.4 (2013): 917-927. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.